Thanks for sharing ywtoh. I found the concluding remarks interesting:
“Results to support process design and calculations are starting to accumulate from both operating commercial plants and full scale testing.”
The MBR research I undertook showed that the accumulation of results and data mirrored the general uptake of the technology (as new information and knowledge was disseminated to key stakeholders).
‘Accumalating’ positive data will strengthen the argument for MABR use and foreshadows sales - a very positive sign.
Add to My Watchlist
What is My Watchlist?
